Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | VNN1 | O95497 | 13/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | CHAT | P28329 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantethine SCHEMBL1650348 | 1.00 | PTGS1 (0.56) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL19544641 | 1.00 | PTGS1 (0.56) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL19358994 | 0.99 | PTGS1 (0.55) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL19359043 | 0.99 | PTGS1 (0.55) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL8416070 | 0.99 | PTGS1 (0.55) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL9112817 | 0.97 | PTGS1 (0.54) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL9115760 | 0.97 | PTGS1 (0.54) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| Pantethine SCHEMBL8416043 | 0.96 | PTGS1 (0.52) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| SCHEMBL18314794 | 0.95 | PTGS1 (0.51) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 | |
| SCHEMBL22369798 | 0.95 | PTGS1 (0.51) | PTGS1KCNH2VNN1ZDHHC20ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5359 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081132-A | Lactobacillus johnsonii DA0207 and application thereof in periplaneta americana fermentation | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4739293-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4739291-A2 | ADMINISTRATION OF KERATOLYTICS TO OCULAR AND PERIOCULAR SURFACES | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260097091-A1 | ADMINISTRATION OF GLUTATHIONE TRISULFIDE TO AMELIORATE PERIPHERAL NEUROPATHY | MASSACHUSETTS GEN HOSPITAL (US) | 2026-04-09 | — | — | US | claimed |
| WO-2026041906-A1 | SEMI-SOLID PHARMACEUTICAL COMPOSITION MICRO-DISPENSER | Azura Ophthalmics Ltd. (IL) | 2026-02-26 | — | — | WO | claimed |
| EP-4691556-A2 | HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF | H. Lundbeck A/S (DK) | 2026-02-11 | — | — | EP | claimed |
| US-20260034171-A1 | Composition for Improving Cognitive Function | PERRY STEPHEN C (US) | 2026-02-05 | — | — | US | claimed |
| US-20250375406-A1 | TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE | VEROSCIENCE LLC (US) | 2025-12-11 | — | — | US | claimed |
| US-4839164-A | ENHANCED PENETRATION OF SKIN | ESTEE LAUDER, INC. (US) | 1989-06-13 | — | — | US | claimed |
| EP-0316438-A1 | CHEMICAL PREVENTION OR REVERSAL OF CATARACT BY PHASE SEPARATION INHIBITORS. | MASSACHUSETTS INST TECHNOLOGY (US) | 1989-05-24 | — | — | EP | claimed |
| WO-1988009660-A2 | CHEMICAL PREVENTION OR REVERSAL OF CATARACT BY PHASE SEPARATION INHIBITORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1988-12-15 | — | — | WO | claimed |
| US-4786493-A | ULTRAVIOLET RADIATION EXPOSURE | ESTEE LAUDER INC. (US) | 1988-11-22 | — | — | US | claimed |
| EP-0131995-B1 | COMPOUNDS WITH HYPOLIPEMIC ACTIVITY | MAGGIONI-WINTHROP S.P.A. (IT) | 1988-02-03 | — | — | EP | claimed |
| EP-0231925-A2 | Hair care compositions | Richardson-Vicks, Inc. (US) | 1987-08-12 | — | — | EP | claimed |
| EP-0223257-A2 | Hair stabilizing composition | ESTEE LAUDER INC. (US) | 1987-05-27 | — | — | EP | claimed |
| EP-0200208-A2 | Pantethine component for hair permanent waving | Richardson-Vicks, Inc. (US) | 1986-11-05 | — | — | EP | claimed |
| EP-0131995-A1 | Compounds with hypolipemic activity | MAGGIONI-WINTHROP S.P.A. (IT) | 1985-01-23 | — | — | EP | claimed |
| US-4060551-A | Method of producing pantethine | SOGO PHARMACEUTICAL COMPANY LIMITED (JA) | 1977-11-29 | — | — | US | claimed |